PixarBio Corporation’s Glenn Reiser To Present Data On Neurorelease, A Breakthrough Non-Opiate And Non-Addictive Pain Platform, At The 2015 Life Sciences Summit In New York, NY

CAMBRIDGE, Mass.--(BUSINESS WIRE)--PixarBio Corporation today announced that Director of Business Development Glenn Reiser will be presenting its breakthrough non-opiate pain platform at the Life Sciences Summit 2015 held in New York, NY on December 1, 2015.

Pixar Bio’s presentation:

Date: Tuesday, December 1, 2015

MORE ON THIS TOPIC